@article{ab1112e6fcf8492d86f26d2492dd7146,
title = "Microstructural associations between locus coeruleus, cortical, and subcortical regions are modulated by astrocyte reactivity: a 7T MRI adult lifespan study",
abstract = "The locus coeruleus–norepinephrine system plays a key role in supporting brain health along the lifespan, notably through its modulatory effects on neuroinflammation. Using ultra–high field diffusion magnetic resonance imaging, we examined whether microstructural properties (neurite density index and orientation dispersion index) in the locus coeruleus were related to those in cortical and subcortical regions, and whether this was modulated by plasma glial fibrillary acidic protein levels, as a proxy of astrocyte reactivity. In our cohort of 60 healthy individuals (30 to 85 yr, 50\% female), higher glial fibrillary acidic protein correlated with lower neurite density index in frontal cortical regions, the hippocampus, and the amygdala. Furthermore, under higher levels of glial fibrillary acidic protein (above \textasciitilde{} 150 pg/mL for cortical and \textasciitilde{} 145 pg/mL for subcortical regions), lower locus coeruleus orientation dispersion index was associated with lower orientation dispersion index in frontotemporal cortical regions and in subcortical regions. Interestingly, individuals with higher locus coeruleus orientation dispersion index exhibited higher orientation dispersion index in these (sub)cortical regions, despite having higher glial fibrillary acidic protein levels. Together, these results suggest that the interaction between locus coeruleus–norepinephrine cells and astrocytes can signal a detrimental or neuroprotective pathway for brain integrity and support the importance of maintaining locus coeruleus neuronal health in aging and in the prevention of age-related neurodegenerative diseases.",
keywords = "aging, brain microstructure, GFAP, locus coeruleus, NODDI",
author = "Elise Beckers and \{Van Egroo\}, Maxime and Ashton, \{Nicholas J.\} and Kaj Blennow and Gilles Vandewalle and Henrik Zetterberg and Poser, \{Benedikt A.\} and Jacobs, \{Heidi I.L.\}",
note = "Funding Information: This work was supported by the Alzheimer Nederland (major award WE.03-2019-02 to HILJ), the National Institutes of Health (R01AG062559, R01AG06806, R01AG082006, and R21AG074220 to HILJ), the BrightFocus Foundation (A20211016F to MVE), the Marie Sk\textbackslash{}u0142odowska-Curie Actions (101109451-ADEEPSLEEP to MVE), and the University of Maastricht\textbackslash{}u2014ULi\textbackslash{}u00E8ge Imaging Valley (to EB, HILJ, and GV). GV is supported by the Belgian Fonds de la Recherche Scientifique (FRS-FNRS; CDR J.0222.20 and PDR T.0242.19) and the University of Li\textbackslash{}u00E8ge (ULi\textbackslash{}u00E8ge). HZ is a Wallenberg Scholar and a Distinguished Professor at the Swedish Research Council supported by grants from the Swedish Research Council (\#2023-00356, \#2022-01018, and \#2019-02397), the European Union\textbackslash{}u2019s Horizon Europe Research and Innovation Program under grant agreement number 101053962, Swedish State Support for Clinical Research (\#ALFGBG-71320), the Alzheimer Drug Discovery Foundation (ADDF), USA (\#201809-2016862), the AD Strategic Fund and the Alzheimer\textbackslash{}u2019s Association (\#ADSF-21-831376-C, \#ADSF-21-831381-C, \#ADSF-21-831377-C, and \#ADSF-24-1284328-C), the Bluefield Project, Cure Alzheimer\textbackslash{}u2019s Fund, the Olav Thon Foundation, the Erling\textbackslash{}u2013Persson Family Foundation, Stiftelsen f\textbackslash{}u00F6r Gamla Tj\textbackslash{}u00E4narinnor, Hj\textbackslash{}u00E4rnfonden, Sweden (\#FO2022-0270), the European Union\textbackslash{}u2019s Horizon 2020 Research and Innovation Program under the Marie Sk\textbackslash{}u0142odowska-Curie grant agreement number 860197 (MIRIADE), the European Union Joint Programme\textbackslash{}u2014Neurodegenerative Disease Research (JPND2021-00694), the National Institute for Health and Care Research University College London Hospitals Biomedical Research Centre, and the UK Dementia Research Institute at UCL (UKDRI-1003). KB is supported by the Swedish Research Council (\#2017-00915), the ADDF, USA (\#RDAPB-201809-2016615), the Swedish Alzheimer Foundation (\#AF-930351, \#AF-939721, and \#AF-968270), Hj\textbackslash{}u00E4rnfonden, Sweden (\#FO2017-0243 and \#ALZ2022-0006), the Swedish state under the agreement between the Swedish government and the County Councils, the ALF-agreement (\#ALFGBG-715986 and \#ALFGBG-965240), the European Union Joint Program for Neurodegenerative Disorders (JPND2019-466-236), the National Institute of Health, USA, (\#1R01AG068398-01), and the Alzheimer\textbackslash{}u2019s Association 2021 Zenith Award (ZEN-21-848495). Publisher Copyright: {\textcopyright} The Author(s) 2024. Published by Oxford University Press.",
year = "2024",
month = jun,
day = "1",
doi = "10.1093/cercor/bhae261",
language = "English",
volume = "34",
journal = "Cerebral Cortex",
issn = "1047-3211",
publisher = "Oxford University Press",
number = "6",
}